Method of using il6 antagonists with proteasome inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2632732

The invention is directed to a method of treating a cancerous disorder or condition, or an IL-6 related disorder or condition, in a mammal in need of such treatment, which comprises co-administering a proteasome inhibitor in combination with an IL-6 antagonist

L'invention concerne un procédé pour traiter un trouble ou un état cancéreux, ou un trouble ou un état impliquant l'interleukine IL-6, chez un mammifère nécessitant un tel traitement. Ce procédé consiste à co-adminitrer un inhibiteur de protéasome en association avec un antagoniste de l'IL-6.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Method of using il6 antagonists with proteasome inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of using il6 antagonists with proteasome inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of using il6 antagonists with proteasome inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2014294

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.